/

Investors / United States / Clarevia

Clarevia

Venture capital · Madison, WI, United States · North America

clarevia.com

Clarevia is an investment firm that focuses on healthcare innovation, backing entrepreneurs and companies working on medical treatments and technologies. It began in 1984 as Madison Capital Corporation and now manages $350 million in assets, working closely with research universities in the Midwest.

Invests inHealthcare & Biotech

In its own wordshealthcarebiotechmedical deviceslife sciencesuniversity spinoutsmidwest

Your fit with Clarevia

Four questions about your startup

See how your round matches what it backs, point by point.

Or find every investor that fits
9portfolio companies
0funding rounds on record

Clarevia lists 9 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 100% of its companies are based in United States. It invests most often alongside Michigan Capital Network, ARCH Venture Partners and Alpha JWC Ventures.

No funding round on record names Clarevia yet, so the figures come from its portfolio page.

Investor profile

percentile among all firms
Portfolio size: 9 companiesRecent activity: 0 rounds in 12 monthsEarly stage: 0% of entries at pre-seed or seedEvidence: 0% of companies confirmed by a roundSector focus: 100% in its largest sectorReach: 1 countryPortfolio size19th pctRecent activity46th pctEarly stage54th pctEvidence52th pctSector focus100th pctReach19th pct
This firmMedian of all firms
Show as a table
Clarevia compared with all firms
MeasurePercentile of all firmsValue
Portfolio size19th9 companies
Recent activity46th0 rounds in 12 months
Early stage54th0% of entries at pre-seed or seed
Evidence52th0% of companies confirmed by a round
Sector focus100th100% in its largest sector
Reach19th1 country

Its portfolio companies

where they are based, and what their own sites show

Headquarters

Site status

  • Site answers9100%
  • No longer answers00%
  • Points to another company00%
  • Parked or sold domain00%

A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.

Investment themes

share of its checked companies

This firmAll checked companies

Show as a table
Investment themes
This firmAll checked companies
Healthcare & Biotech100%15%

Compare Clarevia head to head

portfolio size, rounds, entry stages, themes and the companies both back

Three or more firms at once: portfolio overlap.

Portfolio

9 companies checked against their own sites
CompanyWhat it doesThemesFirst round with itEvidence
BlueWillowbluewillow.com · United StatesBlueWillow Biologics develops intranasal vaccines using its NanoVax platform technology
Healthcare & Biotech
Portfolio page
Cellectarcellectar.com · United StatesCellectar Biosciences, Inc. is developing precision medicine and personalized cancer treatments using its novel Phospholipid Drug Conjugate platform.
Healthcare & Biotech
Portfolio page
EarliPointearlipointhealth.comEarliPoint develops and provides an FDA-cleared autism assessment device for use by qualified clinicians
Healthcare & Biotech
Portfolio page
elephas.comelephas.com · United StatesElephas develops and provides a platform for predicting tumor response to treatment and analyzing live human tissue
Healthcare & Biotech
Portfolio page
Elucentelucent.comElucent Medical develops and provides smart surgical tools with 3D spatial intelligence for precision in surgical procedures.
Healthcare & Biotech
Portfolio page
Ensodataensodata.comEnsoData develops and provides AI-driven solutions for sleep medicine, including sleep diagnostics and therapy tracking.
Healthcare & Biotech
Portfolio page
HistoSonicshistosonics.com · United StatesHistoSonics has developed a non-invasive, sonic beam therapy platform that uses histotripsy to destroy targeted liver tumors at a sub-cellular level.
Healthcare & Biotech
Portfolio page
Invenrainvenra.comInvenra discovers, optimizes, and engineers novel monoclonal, bispecific, and trispecific antibodies for clients
Healthcare & Biotech
Portfolio page
Sanacorsanacor.com
Portfolio page

About this data

site last read 5 Nov 2026
The homepage of Clarevia, as last read
clarevia.com as VCinfo last read it
Site
clarevia.com
Last read
5 Nov 2026
Watching since
6 Nov 2026
Companies checked
9

Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.

How we grade the data

Free account · no card

Get Clarevia's profile as data

Pull Clarevia's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/firms/clarevia.com

# also
GET /v1/firms/clarevia.com/portfolio
GET /v1/firms/clarevia.com/coinvestors
GET /v1/firms/clarevia.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing